Jobs / United States / Astrazeneca Pharmaceuticals Lp

Associate Director, Clinical Supply Logistics & Distribution — Cell Therapy

Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD

Sponsorship verdict

Sponsorship possible

One solid signal, not two — worth applying, and worth asking about sponsorship early.

  • Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
  • The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
  • No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
  • What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
  • Confirmed live todayWhen a source last listed this job as open.

US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).

A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.

Start free →

Or apply yourself on the official page →

Sponsor Radar — Astrazeneca Pharmaceuticals Lp

99 H-1B filings certified since Oct 2025

The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).

Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →

About the role

AstraZeneca is building one of the most ambitious Cell Therapy portfolios in the industry. Our allogeneic and in vivo programs represent the future of how these therapies will be delivered. Unlike patient-specific autologous treatments, these are off-the-shelf therapies designed to be manufactured at scale, inventoried, and delivered on demand. This model has the potential to dramatically expand patient access but requires a new clinical supply approach.   We are seeking an experienced supply chain leader to help design and implement the global clinical supply model for these next-generation programs. The Associate Director, Clinical Supply Logistics and Distribution — Cell Therapy will support the development of the supply chain strategy and operating model for off-the-shelf cell therapy programs, from supply architecture and distribution network design through order fulfillment and site-level delivery.   Working closely with the Executive Director, Patient Supply Operations, Clinical Operations, CMC, Manufacturing, Quality, Regulatory, external logistics providers, and other cross-functional partners, this role will translate clinical development plans into reliable, compliant, and scalable supply solutions. The Associate Director will lead key elements of the operating model, build fit-for-purpose processes, and ensure that every patient enrolled in our trials receives therapy reliably and on time. This is an opportunity to help establish the standards and capabilities for how off-the-shelf cell therapies reach patients worldwide. Key Accountabilities • Support the development of the strategic vision and operating model for the end-to-end clinical supply chain across allogeneic and in vivo programs, including supply architecture, inventory positioning, clinical packaging and labeling, depot strategy, cold chain requirements, lane design, and site delivery models appropriate to each modality. • Develop and maintain clinical supply strategies at the program and study level, translating study designs, enrollment forecasts, pipeline progression, and manufacturing constraints into integrated supply plans with clear assumptions, scenario planning, and risk mitigations. • Lead clinical supply execution from study startup through study completion, ensuring uninterrupted investigational medicinal product delivery to patients across active sites and geographies. • Establish and operate the order management and fulfillment model , including demand signals, allocation logic, release-to-ship workflows, inventory replenishment, site coordination, delivery confirmation, and escalation processes. • Coordinate distribution network operations , including logistics provider governance, packaging and shipping configurations, regional depot partners, temperature monitoring, transit validation, and country-specific import and export requirements for biological materials. • Partner closely with Clinical Operations to provide supply recommendations, risks, mitigations, and required decisions to Global Study Teams and leadership. Ensure clinical supply timelines are integrated into study startup plans, site activation milestones, and enrollment projections. • Provide oversight of clinical packaging and labeling activities performed by third parties, including country-specific requirements and timelines supporting regulatory submissions and clinical study milestones. • Support clinical site enablement from a supply chain perspective, including site feasibility, import pathway confirmation, lane qualification, site-level delivery requirements, and development of training materials. • Implement exception management and escalation processes , enabling rapid triage of supply disruptions, cross-functional mobilization, and timely action to protect

View the official posting →

Source: Employer career site (Workday) First seen: 2026-10-14 Last confirmed: 2026-10-14 How our data works → Report this job

Similar opportunities